ENDRA Life Sciences NDRA
$ 5.8
8.01%
Quarterly report 2024-Q2
added 08-14-2024
Country |
USA |
IPO year |
2017 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Francois Michelon |
Employees in the company |
15 |
Shares |
10.4 M |
Market Cap[1] |
$ 60.3 M |
EBITDA (LTM) |
$ -11.7 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.